This is not the most recent version of the article. View current version (31 MAR 2014)

Intervention Review

Alpha2-adrenergic agonists for the management of opioid withdrawal

  1. Linda Gowing1,*,
  2. Michael Farrell2,
  3. Robert Ali1,
  4. Jason M White1

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 15 APR 2009

Assessed as up-to-date: 26 OCT 2008

DOI: 10.1002/14651858.CD002024.pub3

How to Cite

Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD002024. DOI: 10.1002/14651858.CD002024.pub3.

Author Information

  1. 1

    University of Adelaide, Discipline of Pharmacology, Adelaide, South Australia, Australia

  2. 2

    National Addiction Centre, Institute of Psychiatry, London, UK

*Linda Gowing, Discipline of Pharmacology, University of Adelaide, Frome Road, Adelaide, South Australia, 5005, Australia. linda.gowing@adelaide.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (31 MAR 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A Esmaeili, AK Keinhorst, T Schuster, F Beske, R Schlösser, C Bastanier, Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate, Acta Paediatrica, 2010, 99, 2